Articles On Nuheara (ASX:NUH)

The acid test of a company’s progress and prospects is when it enters the crosshairs of a potential acquirer, which is exactly what’s happened with the ‘hearables’ device developer. On June 25, Nuheara disclosed in a broader update that it...

Australia is home to some of the top physicians as well as healthcare professionals. For more than 30 years, various companies across the globe have depended on the clinical trial in Australia and its capability to deliver timely results wi...

Nuheara (ASX:NUH) has responded to an ASX query surrounding rumours Samsung made a $84m takeover bid for junior earbuds maker. The company clarified that it had received an “indicative non-binding letter of intent” from American sound compa...

Given the dynamic nature of businesses, which are prone to changes very often, companies require some time to hold their trading either to focus on an announcement or regulation, or in case of a much serious issue, that requires the trading...

The Nuheara Ltd (ASX: NUH) share price will be one to watch when it returns from its trading halt. On Wednesday the hearing solutions company requested a trading halt whilst it conducted a bookbuild for a placement of ordinary shares to in...

Earbuds maker Nuheara (ASX:NUH) surprised and dismayed the market this morning telling investors it received a takeover offer in April and is scrapping a new product unveiled in January last year. Nuheara did not identify the “large multina...

The two ASX traded companies BOT and NHS  had updated investors about the latest developments in the market. With a positive YTD return, both stocks have gained momentum over the past few months. Botanix Pharmaceuticals Limited (ASX: BOT) S...

The Gent's Manifesto: My Journey And Investment Philosophy Ethical Equities Founder, Claude Walker has suggested that I share with readers some background on my investing journey to date. This is my own fault and the just desserts for my h...